NCT04125043

Brief Summary

This study is designed to investigate the sensitivity and specificity of the Red Reflex Test (RRT), with and without dilation, for early detection of ocular abnormalities in children and newborns. The RRT functions by shining a light from an ophthalmoscope into a participant's eye and noting the presence or absence of a red glow. Despite its use in pediatric clinics for years, this test at times fails to detect significant ocular diseases, especially located in the back of the eye, threatening visual development in this population. Therefore, the investigators aim to quantify the utility of this test as a tool for screening by comparing these findings on RRT with those of retinal photography. The investigators hypothesize that the sensitivity and specificity of the RRT will be sufficient for detecting anterior segment pathology but will be insufficient for detecting posterior segment pathology with or without dilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 14, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

3.3 years

First QC Date

October 10, 2019

Last Update Submit

October 19, 2023

Conditions

Keywords

Red reflexPosterior ocular abnormalities

Outcome Measures

Primary Outcomes (1)

  • Sensitivity and Specificity of RRT

    sensitivity and specificity of the RRT in detecting anterior segment pathology, as well as the sensitivity and specificity of the RRT in detecting posterior segment pathology

    1 year

Secondary Outcomes (1)

  • Sensitivity and Specificity of RRT with Dilation

    1 year

Study Arms (1)

RRT Group

Pediatric patients undergoing ocular screening tests

Diagnostic Test: Direct ophthalmoscope

Interventions

Direct ophthalmoscopeDIAGNOSTIC_TEST

Red reflex test

RRT Group

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Pediatric patients under 18 years old recruited in clinical practice with known anterior or posterior segment pathology as well as patients without anterior or posterior segment pathology.

You may qualify if:

  • Pediatric patients recruited in clinical practice with known anterior or posterior segment pathology as well as patients without anterior or posterior segment pathology

You may not qualify if:

  • Patients who have a history of disease, treatments and/or surgical procedures affecting the ability for normal pupillary reaction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's National Medical Center

Washington D.C., District of Columbia, 20010, United States

Location

MeSH Terms

Conditions

Optic Nerve DiseasesRetinal DiseasesRetinal Hemorrhage

Condition Hierarchy (Ancestors)

Cranial Nerve DiseasesNervous System DiseasesEye DiseasesEye HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • William P Madigan, MD

    Children's National Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Division of Ophtamology

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 14, 2019

Study Start

March 1, 2020

Primary Completion

July 1, 2023

Study Completion

August 1, 2023

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations